文献速递肺栓塞与肺血管病

学校心电图筛查检测儿童肺动脉高压

Detection of Pediatric Pulmonary Arterial Hypertension by School Electrocardiography Mass Screening.
PubMed 文献 · Am J Respir Crit Care Med · 2019-01-01

日本全国性调查纳入2005-2012年新诊断的3月龄至18岁特发性或遗传性肺动脉高压患者,评估学校心电图筛查对检出该病的影响。结果显示筛查组诊断时WHO功能分级I/II比例更高、脑钠肽更低、6分钟步行距离更长,且最终静脉依前列醇使用比例更低,尽管两组平均肺动脉压和肺血管阻力指数相似。

要点

  • 学校心电图筛查可检出已存在肺动脉高压但无明显右心衰竭的儿童患者。
  • 筛查组诊断时功能状态和运动能力优于非筛查组,静脉依前列醇使用更少。
  • 筛查组与非筛查组的平均肺动脉压和肺血管阻力指数无显著差异。

核心结论

  • 基于心电图的筛查可检测出儿童特发性或遗传性肺动脉高压的独特亚群,该亚群已建立肺动脉高压但无明显的右心衰竭。
  • 筛查组的诊断时功能状态、脑钠肽水平和6分钟步行距离优于非筛查组,且最终静脉依前列醇使用比例更低。

研究设计与样本

  • 日本全国性调查,纳入2005-2012年新诊断的3月龄至18岁特发性或遗传性肺动脉高压患者。

主要发现

  • 在68例(78%)年龄≥6岁(首次心电图筛查年龄)的患者中,28例(41%)通过心电图筛查检出(筛查组),40例(59%)通过症状(n=37)或偶然机会(n=3)发现(非筛查组)。
  • 筛查组诊断时WHO功能分级I/II的比例为96%,非筛查组为60%(P<0.001)。
  • 筛查组血浆脑钠肽水平为149±290 pg/ml,非筛查组为398±559 pg/ml(P=0.045)。
  • 筛查组6分钟步行距离为420±109 m,非筛查组为327±104 m(P<0.001)。
  • 筛查组平均肺动脉压为58±17 mm Hg,非筛查组为61±17 mm Hg(P=0.42);筛查组肺血管阻力指数为18±8 Wood units·m2,非筛查组为21±11 Wood units·m2(P=0.24)。

临床怎么用

  • 学校心电图筛查可能有助于在儿童中早期发现特发性或遗传性肺动脉高压,使患者在右心衰竭出现前得到诊断。

局限性

  • 原文未明确报告研究的局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: To detect pulmonary arterial hypertension (PAH) at any early stage is a promising approach to optimize the outcome. Objectives: To investigate the impact of school ECG-based screening on detecting idiopathic or heritable (I/H)-PAH in the general pediatric population. Methods: This was a nationwide survey of patients with I/H-PAH newly diagnosed at 3 months to 18 years of age in Japan during 2005-2012. Measurements and Main Results: Eighty-seven eligible patients (age range, 1-16 yr) were recruited. Among 68 (78%) patients diagnosed at greater than or equal to 6 years of age (the age of the first ECG-based screening), 28 (41%) were detected by the ECG-based screening (screening group) and 40 (59%) were recognized by their symptoms (n = 37) or coincidental occasions (n = 3; nonscreening group). In the screening group, the proportion of patients in World Health Organization functional class I/II at diagnosis was higher (96% vs. 60%; P < 0.001), plasma brain natriuretic peptide level was lower (149 ± 290 vs. 398 ± 559 pg/ml; P = 0.045), and 6-minute-walk distance was longer (420 ± 109 vs. 327 ± 104 m; P < 0.001) than the nonscreening group, despite similar values in mean pulmonary artery pressure (58 ± 17 vs. 61 ± 17 mm Hg; P = 0.42) and pulmonary vascular resistance index (18 ± 8 vs. 21 ± 11 Wood units ⋅ m2; P = 0.24) between groups. The proportion of patients on intravenous epoprostenol at the final visit was lower in the screening group than the nonscreening group (14% vs. 50; P = 0.004). Conclusions: These findings suggest that the ECG-based screening detects a unique subpopulation of pediatric patients with I/H-PAH that is associated with already established pulmonary hypertension but without obvious right heart failure and warrants investigating the prognostic significance of this system.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Sawada H, Mitani Y, Nakayama T, et al. Detection of Pediatric Pulmonary Arterial Hypertension by School Electrocardiography Mass Screening. Am J Respir Crit Care Med. 2019. PMID: 30428270. doi:10.1164/rccm.201802-0375OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。